| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,074,897 | 1,155,453 | 1,188,023 | 1,111,826 | | Cost of Revenue | (432,277) | 448,115 | 464,213 | 612,984 | | | Gross Profit | 1,507,174 | 707,338 | 723,810 | 498,842 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,220,258 | 393,130 | 396,434 | 221,868 | | Non Recurring | 134,828 | 285,488 |
-
| 130,229 | | Others | 57,721 | (83,422) | 204,899 | 60,455 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 94,811 | 112,142 | 122,477 | 86,290 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 902 | 2,058 | 16,677 | 27,168 | | Earnings Before Interest And Taxes | 95,269 | 114,200 | 139,154 | 108,204 | | Interest Expense | 54,192 | 54,282 | 55,011 | 61,663 | | Income Before Tax | 41,077 | 59,918 | 84,143 | 46,541 | | Income Tax Expense | 11,706 | 20,620 | 30,066 | 17,498 | | Minority Interest | (6,476) | (13,258) |
-
| (5,254) | | | | Net Income From Continuing Ops | 42,629 | 26,040 | 54,077 | 29,043 | | | Non-recurring Events | | Discontinued Operations | 2,550 |
-
| (1,508) | (14,494) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,445 | 26,040 | 52,569 | 14,549 | | Preferred Stock And Other Adjustments |
-
| 6,553 | (6,553) |
-
| | | Net Income Applicable To Common Shares | $25,445 | $32,593 | $46,016 | $14,549 |
|
0.11% Nasdaq 
0.01%
Income Statement
